Invention Grant
- Patent Title: Chemical compounds
-
Application No.: US15840339Application Date: 2017-12-13
-
Publication No.: US10336725B2Publication Date: 2019-07-02
- Inventor: Susanne Elisabeth Berglund , Stephen Connolly , Martin Hemmerling , Nafizal Hossain , Anna Kristoffersson , Johan Rune Michael Lundkvist , Grigorios Nikitidis , Lena Elisabeth Ripa , Igor Shamovsky
- Applicant: AstraZeneca AB
- Applicant Address: SE Sodertalje
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE Sodertalje
- Main IPC: C07D401/12
- IPC: C07D401/12 ; C07D241/26 ; A61K31/4965 ; A61K45/06 ; A61K31/497 ; C07D401/06 ; C07D241/28
Abstract:
The present invention provides a compound of a formula (I): or a pharmaceutically acceptable salt thereof; a process for preparing such a compound; and to the use of such a compound in the treatment of an ENaC mediated disease state (such as asthma, CF or COPD).
Public/Granted literature
- US20180162838A1 Chemical Compounds Public/Granted day:2018-06-14
Information query
